These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

815 related articles for article (PubMed ID: 31792399)

  • 1. Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases.
    Hinz B; Lagares D
    Nat Rev Rheumatol; 2020 Jan; 16(1):11-31. PubMed ID: 31792399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis.
    Lagares D; Santos A; Grasberger PE; Liu F; Probst CK; Rahimi RA; Sakai N; Kuehl T; Ryan J; Bhola P; Montero J; Kapoor M; Baron M; Varelas X; Tschumperlin DJ; Letai A; Tager AM
    Sci Transl Med; 2017 Dec; 9(420):. PubMed ID: 29237758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix Stiffness: the Conductor of Organ Fibrosis.
    Santos A; Lagares D
    Curr Rheumatol Rep; 2018 Jan; 20(1):2. PubMed ID: 29349703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for Studying Myofibroblast Apoptotic Pathways.
    Zhou Y; Lagares D
    Methods Mol Biol; 2021; 2299():123-137. PubMed ID: 34028739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Pro-fibrotic Myofibroblasts in Systemic Sclerosis: From Origin to Therapeutic Targeting.
    Romano E; Rosa I; Fioretto BS; Matucci-Cerinic M; Manetti M
    Curr Mol Med; 2022; 22(3):209-239. PubMed ID: 33823766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
    Cho N; Razipour SE; McCain ML
    Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myofibroblast fate plasticity in tissue repair and fibrosis: Deactivation, apoptosis, senescence and reprogramming.
    Merkt W; Zhou Y; Han H; Lagares D
    Wound Repair Regen; 2021 Jul; 29(4):678-691. PubMed ID: 34117675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy.
    Di Benedetto P; Liakouli V; Ruscitti P; Berardicurti O; Carubbi F; Panzera N; Di Bartolomeo S; Guggino G; Ciccia F; Triolo G; Cipriani P; Giacomelli R
    Arthritis Res Ther; 2018 Oct; 20(1):223. PubMed ID: 30285896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BH3 mimetics as anti-fibrotic therapy: Unleashing the mitochondrial pathway of apoptosis in myofibroblasts.
    Kuehl T; Lagares D
    Matrix Biol; 2018 Aug; 68-69():94-105. PubMed ID: 29408011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease.
    Kramann R; DiRocco DP; Humphreys BD
    J Pathol; 2013 Nov; 231(3):273-89. PubMed ID: 24006178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of organ fibrosis.
    Jun JI; Lau LF
    J Clin Invest; 2018 Jan; 128(1):97-107. PubMed ID: 29293097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Fibrotic Diseases: Current Challenges in Fibrosis Research.
    Rosenbloom J; Macarak E; Piera-Velazquez S; Jimenez SA
    Methods Mol Biol; 2017; 1627():1-23. PubMed ID: 28836191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of fibrotic changes by the synergistic effects of cytokines, dimensionality and matrix: Towards the development of an in vitro human dermal hypertrophic scar model.
    Chawla S; Ghosh S
    Acta Biomater; 2018 Mar; 69():131-145. PubMed ID: 29330036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-β-induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosis.
    Dees C; Pötter S; Zhang Y; Bergmann C; Zhou X; Luber M; Wohlfahrt T; Karouzakis E; Ramming A; Gelse K; Yoshimura A; Jaenisch R; Distler O; Schett G; Distler JH
    J Clin Invest; 2020 May; 130(5):2347-2363. PubMed ID: 31990678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis.
    Martin K; Pritchett J; Llewellyn J; Mullan AF; Athwal VS; Dobie R; Harvey E; Zeef L; Farrow S; Streuli C; Henderson NC; Friedman SL; Hanley NA; Piper Hanley K
    Nat Commun; 2016 Aug; 7():12502. PubMed ID: 27535340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into myofibroblasts and their activation in scleroderma: opportunities for therapy?
    Gyftaki-Venieri DA; Abraham DJ; Ponticos M
    Curr Opin Rheumatol; 2018 Nov; 30(6):581-587. PubMed ID: 30074511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of endothelial cells to tissue fibrosis.
    Romano E; Rosa I; Fioretto BS; Manetti M
    Curr Opin Rheumatol; 2024 Jan; 36(1):52-60. PubMed ID: 37582200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New developments on skin fibrosis - Essential signals emanating from the extracellular matrix for the control of myofibroblasts.
    Schulz JN; Plomann M; Sengle G; Gullberg D; Krieg T; Eckes B
    Matrix Biol; 2018 Aug; 68-69():522-532. PubMed ID: 29408278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host responses in tissue repair and fibrosis.
    Duffield JS; Lupher M; Thannickal VJ; Wynn TA
    Annu Rev Pathol; 2013 Jan; 8():241-76. PubMed ID: 23092186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox signaling as a therapeutic target to inhibit myofibroblast activation in degenerative fibrotic disease.
    Sampson N; Berger P; Zenzmaier C
    Biomed Res Int; 2014; 2014():131737. PubMed ID: 24701562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.